GENERAL
Pancreatic Cancer Vaccine Shows Promise in Early Trials
A new experimental mRNA vaccine, personalized for each patient's tumor, is showing significant promise in early trials for pancreatic cancer. Donna Guffkasen, a trial participant, has been cancer-free for six years thanks to the treatment. Researchers hope this breakthrough could lead to new ways to fight the notoriously difficult disease.